Metformine Hydrochloride Eg (Eurogenerics)

Metformin Hydrochloride, the active ingredient in Metformine Hydrochloride Eg, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus and polycystic ovary syndrome in adults, helping to control blood glucose levels as part of a comprehensive management plan.

GNH USA supplies Metformine Hydrochloride Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is used to improve glycaemic control in several metabolic conditions.

Type 2 diabetes mellitus: improves fasting and post‑prandial blood glucose levels. Polycystic ovary syndrome: reduces insulin resistance and may help restore regular menstrual cycles. Prediabetes (impaired fasting glucose): lowers the risk of progression to overt diabetes.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: frequent loose stools, especially at treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: when combined with insulin or secretagogues. - Vitamin B12 deficiency: may develop with long‑term use. - Hepatic dysfunction: rare liver enzyme elevations. - Skin rash or hypersensitivity: including Stevens‑Johnson syndrome. - Pancreatitis: very uncommon inflammation of the pancreas.

Before prescribing Metformin Hydrochloride, clinicians should evaluate several safety considerations.

Renal function assessment: confirm adequate eGFR before initiation and monitor periodically. Lactic acidosis risk: avoid in patients with severe renal, hepatic or cardiac impairment. Pregnancy safety: use only if potential benefit justifies potential risk to the fetus. Drug interaction monitoring: review concomitant medications that may affect metformin clearance. Vitamin B12 monitoring: consider periodic testing during long‑term therapy. Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Hydrochloride can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment. - Thiazide diuretics: may increase risk of hypoglycaemia. - NSAIDs: can impair renal clearance of metformin.